LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Mercy BioAnalytics

Mercy BioAnalytics is dedicated to developing the means to detect cancer at an early stage. We are actively creating and validating the instrumentation necessary to detect multiple stage I solid tumors from a single blood draw with adequate sensitivity and ultra-high specificity (>99.9%). By helping patients find their cancer early, we hope to provide a better shot at a cure. 

  • Joseph Sedlak Scientific Founder
  • Paul Blavin, MBA Co-Founder, Chairman of the Board
  • Laura Bortolin, PhD Senior Research Scientist